NET PROFIT (x1000 NOK)
EMPLOYEES
Magle Biopolymers A/S
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-43,278
|
6,951
|
14,702 |
| Total assets |
525,016
|
542,844
|
487,769 |
| Current assets |
135,173
|
147,442
|
109,093 |
| Current liabilities |
231,907
|
135,847
|
100,216 |
| Equity capital |
246,832
|
283,403
|
260,855 |
| - share capital |
5,558
|
5,279
|
4,954 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.0%
|
52.2%
|
53.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
58.3%
|
108.5%
|
108.9% |
| Return on equity (ROE) |
-17.5%
|
2.5%
|
5.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.